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Purpose: To compare the clinical effects of phacoemulsification (PHACO) combined with goniosynechialysis (GSL) at
different times in the treatment of primary angle-closure glaucoma (PACG) combined with cataract.
Methods: Before surgery, one or more different kinds of anti-glaucoma medicines were used for 24 patients (32 eyes) of
PACG combined with cataract. A combination of PHACO with GSL procedures were performed on both groups of
patients. The patients were randomly divided into two groups: 17 patients with 21 eyes were in Group A (GSL performed
before lens was removed) and 7 patients with 11 eyes in Group B (GSL after extraction of crystal cortex). Changes in
visual acuity, intraocular pressure (IOP) and the depth of the center anterior chamber were observed before surgery and
again at 1 month, 3 months, 6 months, and 12 months after surgery.
Results: The mean visual acuity of Group A and Group B was 1.13±0.75 and 0.93±0.50, respectively. There was no
statistical difference between these two groups in visual acuity before surgery. At 1 month, 3 months, 6 months, and 12
months after surgery, the visual acuities in Group A were 0.57±0.33, 0.42±0.24, 0.30±0.23, 0.35±0.28 and the visual
acuities in Group B were 0.68±0.60, 0.38±0.15, 0.40±0.17,0.33±0.13, and 0.37±0.06. Visual acuity after surgery was
greatly improved in both groups. However, there was no difference between these two groups at the different points in
time mentioned above. The mean IOP before surgery was 35.67±12.31 mmHg and 31.64±15.06 mmHg for Group A and
Group B, respectively. At 1 month, 3 months, 6 months, and 12 months after surgery, the IOP were normalized and were
significantly lower than before surgery, in group A and B. However, there was no difference in IOP between these groups
at the different points in time as mentioned above. One year after surgery, the percentages of success in Group A and
Group B were 86.0% and 90.0%, respectively, qualifid success rates in Group A and Group B were 9.5% and 10.0%,
respectively. The failure rate in Group A was 4.8%, and no one failed in Group B. In Group A, the number of medications
pre-operation was 2.05±0.74. A trabeculectomy was performed on 1 eye, and anti-glaucoma medicines were used for 2
eyes after surgery to normalize IOP. In Group B, the number of medications pre-operation was 2.18±0.87. One anti-
glaucoma medicine- was used for 1 eyes. In different period after surgery, anterior chamber angles in Group A were all
open. Narrow anterior chamber angles in different extents also were observed in 4 eyes in Group B. The mean depth of
the center anterior chamber before surgery was 1.56±0.37 mmHg and 1.72±0.35 mmHg for Group A and Group B,
respectively. At 1 month, 3 months, 6 months and 12 months after surgery, the center anterior chamber was deeper than
that before surgery both in both groups . However, there was no difference in the center anterior chamber’s depth between
these groups at the different points in time mentioned above.
Conclusions: For PACG patients with cataracts, surgery methods are shown to improve visual acuity, decrease IOP, and
expand the anterior chamber angle. Regarding the opening extent of the anterior chamber angle, surgery performed on
Group A achieved better results than Group B.
As  previously  documented,  long-standing  peripheral
anterior synechiae (PAS) were associated with permanent
trabecular  damage  [1,2].  It  was  reported  that
goniosynechialysis (GSL) was performed by Shaffer [3] to
treat angle-closure glaucoma in 1957. Thereafter, the surgery
has been continually improved. In 1984, the method proposed
by Campbell, et al. [1] to expand the chamber angle using
viscoelastic  material  in  surgery  was  in  practice.  In  the
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Campbell et al. [1,4] method, GSL is performed after the lens
is removed. Additionally, a viscoelastic agent was used to
expand  the  chamber  angle.  The  surgical  results  varied
according to the reports. In our study of the timing of GSL in
the surgery, we performed GSLs before and after PHACOs to
compare the effects of two types of surgeries so as to find the
best way to treat primary angle-closure glaucoma (PACG)
combined with cataract.
METHODS
General information: This study adhered to the tenets of the
Declaration of Helsinki. All participants signed the respective
informed consent forms. The research was approved by the
Ethics Committee of the Research Institute of Field Surgery,
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Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical University, Chongqing,
P.R. ChinaDa  Ping  Hospital,  Third  Military  Medical  University,
Chongqing, P.R. China. Thirty-nine patients (52 eyes) with
chronic angle-closure glaucoma with cataract were admitted
to participate and were treated by us from June 2010 to June
2011: all patients were randomized into 2 groups (Group A or
Group B) using a random number table created by SPSS
statistical software (SPSS version 13.0; SPSS, Chicago, IL).
Group A consisted of 20 patients and Group B consisted of 19
patients. Eight patients in Group A had PACG and cataracts
in  both  eyes,  and  5  patients  in  Group  B  had  PACG  and
cataracts. Fifteen patients did not return to us during the study.
Among the remaining 24 participants, 4 patients from both
Group A and Group B suffered PACG and cataracts in both
eyes Ten patients (14 eyes) were male and 14 cases (18 eyes)
were  female.  The  mean  age  of  participants  was  67.4±5.6
years. The lenses of all patients were nepheloid to different
degrees. The degrees of cataract in all patients’ eyes were CII
or CIII [5] according to the Lens Opacities Classification
System, version II (LOCS II). The degrees of nuclear hardness
in all eyes were equal to or more than grade III according to
the  Emery  and  Little  nuclear  hardness  classification.
According  to  the  results  of  gonioscope  and  ultrasound
biomicroscopy (UBM) examinations before surgery, anterior
chamber angles had narrowed to different degrees (Figure 1
and Figure 2). The visual acuities of 10 eyes were between
light perception and 0.1. The visual acuities of the other 24
eyes were between 0.1 and 0.5. The comparison of gender,
age and visual acuity of patients between these two groups
was free of statistical difference.
Case series:
The inclusion criteria were as follows—1. Occludable
angle  confirmed  by  gonioscopy  (OMVGLF-1.5X):  the
gonioscope examinations were performed in a darkened room
with minimum-possible slit-lamp illumination, making sure
that the slit beam did not impinge upon the pupil [6]. The
extent of posterior goniosynechia of the included patient was
one-third to three-quarters.
2. Evidence was found of uncontrolled IOP (raised IOP,
progressive  glaucomatous  optic  neuropathy,  and/or  visual
field progression).
3. All patients conformed to the diagnose standard of
angle-closure glaucoma proposed by Foster et al. [7] in 2002:
people meeting gonioscopic criteria for narrow angles and
with  evidence  of  significant  obstruction  of  the  functional
trabecular meshwork by the peripheral iris would be classified
as having primary angle closure (PAC). Those in whom PAC
had led to significant glaucomatous damage to the optic nerve
would be defined as having PACG.
Exclusion criteria included—1. Plateau iris syndrome.
2.  Previous  glaucoma  surgery  (argon  laser/
trabeculoplasty/trabeculectomy).
3. Retinal disease.
4. History of ocular injury.
5. Previous patent PI.
6. Other glaucomas.
Figure 1. The group A show the chamber
angle are closed pre-operation (in terms
of UBM).
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1075Preoperatively  and  postoperatively,  all  patients
underwent complete ocular examination.
Treatment—Phacomulsification,  intraocular  lens
implantation,  and  GSL  were  performed  on  39  patients.
Phacomulsification was performed as the usual method of
surgical operation, but 1 ml viscoelastic material was used,
rather than 0.5 ml. In Group A, after an incision was performed
on the transparent cornea, viscoelastic material was filled in
the anterior chamber to achieve more depth at the anterior
chamber. Next approximately 0.5 ml viscoelastic material was
placed near the anterior angle to blunt dissect the anterior
chamber in 360° and separate PAS. In Group B, after an
incision was performed on the transparent cornea, a small
amount of viscoelastic material was filled as described in the
usual practice to achieve more depth at the anterior chamber.
After the removal of lens cortical material by an irrigation-
aspiration (I/A) probe, about 0.5 ml viscoelastic material was
placed near the anterior angle to blunt dissect the anterior
chamber in 360° and separate PAS. In both Group A and
Group B, it was ensured that the tip did not have contact with
trabecular  meshwork.  In  the  two  types  of  surgeries,
gonioscope  (O4MAC)  was  used  to  observe  the  opening
degree of the anterior angle after GSL. If any residual PAS
was found at the root of the iris after GSL, a blunt instrument
was used to press the root of the iris and resolve the remaining
PAS. Eye patches of all patients were removed one day after
the surgery. Hormone eye drops and non-corticosteroid eye
drops were prescribed for the eyes.
Visits—Visual  acuity,  IOP,  slit  lamp,  UBM,  and  a
rotating  Scheimpflug  camera  (Pentacam)  were  performed
before surgery and at 1 month, 3 months, 6 months and 12
months after the surgery. The technicians who performed the
IOP examination, Pentacam, UBM et al., were masked to
group assignment.
Statistical  handling:  Data  were  expressed  as  the  mean
±standard deviation (SD). A p value below 0.05 was taken as
a  statistically  significant  difference.  The  analysis  was
performed using SPSS software (SPSS version 13.0; SPSS,
Chicago, IL).
RESULTS
Visual acuity: The mean visual acuities of Group A and Group
B were 1.13±0.75 and 0.93±0.50 respectively. There was no
statistical difference between these two groups in visual acuity
before surgery. At 1 month, 3 months, 6 months, and 12
months after surgery, the visual acuities in Group A were
0.57±0.33  (p=0.000),  0.42±0.24  (p=0.000),  0.30±0.23
(p=0.000), 0.35±0.28 (p=0.003; Figure 3). The visual acuities
in Group B were 0.38±0.15 (p=0.000), 0.40±0.17 (p=0.003),
0.33±0.13 (p=0.007), 0.37±0.06 (p=0.035; Figure 4). Visual
acuity of all patients in both groups increased after the surgery.
No appreciable difference (p>0.05) was observed in the visual
acuity between these two groups at 1 month, 3 months, 6
months, and 12 months after the surgery.
IOP and anti-glaucoma medicine for decreasing IOP: Before
surgery,  the  mean  IOP  was  35.67±12.31  mmHg  and
31.64±15.06 mmHg for groups A and B, respectively. At 1
Figure 2. The group B show the chamber
angle are closed pre-operation (in terms
of UBM).
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1076month, 3 months, and 6 months after surgery, the IOPs of
Group A were 10.33±2.80 (p=0.000), 10.13±2.58 (p=0.000),
11.00±2.27 (p=0.000), 10.00±1.41 (p=0.001; Figure 5). The
IOPs of Group B were 12.20±2.90 (p=0.001), 12.13±2.95
(p=0.002), 13.00±2.31 (p=0.002), and 15.67±3.79 (p=0.002;
Figure  6).  The  IOPs  of  all  patients  were  normalized  and
significantly lower than before surgery both in Group A and
Group B. However, there was no difference of IOP between
these groups at the different time points mentioned above.
In  our  study,  complete  success  was  defined  as  IOP
remaining <21 mmHg with no additional medication, while
qualified success was defined as those requiring additional
anti-glaucoma medication, and failure was defined as
1. Patients’ postoperative visual acuity dropping to
no light perception,
2. IOP> 21 mmHg in two consecutive follow-ups
on patients with anti-glaucoma medications,
3. and  patients  who  required  another  anti-
glaucoma operation [8].
In Group A, one eye showed increased IOP again on the
third  day  after  surgery.  Anti-glaucoma  medicine  was
prescribed  to  decrease  the  IOP  but  had  no  effect.  A
trabeculectomy was performed on the eye. IOP was controlled
within the normal scope after the surgery. IOP of one eye
fluctuated between 20 mmHg and 25 mmHg after the surgery.
Two kinds of anti-glaucoma medicines were prescribed as
treatment and the IOP was normalized. The IOP of one eye
was 21 mmHg at 11 months after the surgery. Anti-glaucoma
medicine was applied locally as treatment and the IOP was
controlled within the normal scope. No further anti-glaucoma
medicines were used on the other patients.
In Group B, 2 eyes showed bleeding during surgery when
blunt instruments were used to separate the root of the iris.
When  hemostasis  therapy  was  taken  after  the  surgery,
hematocele in the anterior chamber was completely absorbed.
Three  eyes  showed  raised  IOP  on  the  first  day  after  the
Figure 3. In group A, the best-corrected
visual acuity (in terms of logMAR) pre-
operation and at 1 month, 3 month, 6
month, and 12 month after operation, the
bars mean the average of the test, the
error bars mean standard deviation.
Figure 4. In group B, the best-corrected
visual acuity (in terms of logMAR) pre-
operation and at 1 month, 3 month, 6
month, and 12 month after operation, the
bars mean the average of the test, the
error bars mean standard deviation.
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1077surgery, fluctuating between 21 mmHg and 31 mmHg. One
patient’s eye’s IOP needed anti-glaucoma medicine to control
IOP and the patient’s eyes IOP became normal on the second
day after surgery.
UBM  observation:  After  surgery,  iris  roots  of  21  eyes  in
Group A opened up more or less. In Group B, 7 out of 11 eyes
(including separation due to mechanical pressing for 4 eyes)
opened up, and the other 4 eyes developed synechia after
surgery.
The depth of the center anterior chamber: The mean depth of
the  center  anterior  chamber  before  surgery  was
1.56±0.37 mmHg and 1.72±0.35 mmHg for Group A and
Group B, respectively. At 1 month, 3 months, 6 months, and
12  months  after  surgery,  the  depths  of  Group  A  were
3.40±0.46  (p=0.000),  3.50±0.57  (p=0.000),  3.59±0.48
(p=0.000), 3.59±0.19 (p=0.000; Figure 7), and the depth of
Group B were 3.69±0.42 (p=0.000), 3.69±0.45 (p=0.000),
3.67±0.16 (p=0.000), and 3.75±0.35 (p=0.000; Figure 8). The
depth of all patients’ center anterior chamber was deeper than
that before surgery in both Group A and Group B. However,
there was no difference in the center anterior chamber’s depth
between these groups at different points in time, as mentioned
above.
The change of the visual field: In this study, we used the mean
deviation (MD, in db; measured with the Humphrey Field
Analyzer) to evaluate the visual field abnormality. MD values
reflected extensive damage of the retinas. The more severe the
damage to the retina was, the lower the value of the MD. Each
p value corresponds to a MD value. The p value indicates the
probability of that MD being found in the normal population.
The MD in Group A ranged from 3.68 db to 24.13 db, with a
mean value of 10.55 db (SD=7.14) ; in Group B the MD
ranged from 3.82 db to 24.92 db, with a mean value of 11.93 db
(SD=6.08) before surgery. At 1 month, 3 months, 6 months,
and 12 months after surgery, the MD values were lower than
that  before  surgery.  However,  there  was  no  statistical
significance  in  MD  and  corresponding  p  value  between
different time points.
The change of the cup/disc ratio: In this study, we used the
cup/disc ratio (C/D; measured with the ZEISS Stratus OCT
Figure 5. In group A, the IOP (in terms
of Goldman IOP) pre-operation and at 1
month, 3 month, 6 month, and 12 month
after  operation,  the  bars  mean  the
average of the test, the error bars mean
standard deviation.
Figure 6. In group B, the IOP (in terms
of Goldman IOP) pre-operation and at 1
month, 3 month, 6 month, and 12 month
after  operation,  the  bars  mean  the
average of the test, the error bars mean
standard deviation.
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10783000; Carl Zeiss Meditec, Dublin, CA) to evaluate the C/D
ratio. The more severe the optic nerve damage, the higher the
value of C/D. The C/D in Group A ranged from 0.38 db to
0.87, with a mean value of 0.61 (SD=0.16); in Group B the C/
D ranged from 0.45 db to 0.78, with a mean value of 0.65
(SD=0.11) before surgery. At 1 month, 3 months, 6 months,
and 12 months after surgery, the C/D value were almost the
same as before surgery in both groups A and B, with no
statistical significances.
Complications: Corneal edema developed in the patients of
both groups after surgery, with a 100% ratio of occurrence.
No bleeding occurred in the anterior chamber for Group A
during the surgery. The iris roots of 4 eyes in Group B were
mechanically pressed during in the surgery to separate PAS,
and 2 eyes showed a small amount of bleeding in the anterior
chamber on the second day after surgery. The blood was
completely absorbed on the third day after the surgery.
DISCUSSION
Clinically, more and more doctors begin to accept PHACO
combined with GSL as the usual surgery to treat PACG with
cataract  [9,10].  The  general  outcome  of  the  surgery  was
positive with few side effects. Most patients no longer needed
to use anti-glaucoma medicines, which could in turn result in
less financial stress for them. However, there still remains the
Figure  7.  The  group  A  shows  the
anterior  chamber  depth  (in  terms  of
Pentacam)  pre-operation  and  at  1
month, 3 month, 6 month, and 12 month
after  operation,  the  bars  mean  the
average of the test, the error bars mean
standard deviation.
Figure 8. The group B shows the anterior
chamber depth (in terms of Pentacam)
pre-operation and at 1 month, 3 month,
6 month, and 12 month after operation,
the bars mean the average of the test, the
error bars mean standard deviation.
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1079question of when to perform this surgery to achieve the best
results. According to the documentations [2,4,9-11], all the
doctors choose to perform GSL after phacoemulsification, and
the  rate  of  success  varied  [12-14].  Through  clinical
observation  during  the  surgery,  we  find  that  the  central
anterior chamber in Group B was significantly deeper than in
Group A during the surgery. This may be the reason why so
many surgeons prefer to perform GSL after the crystalline lens
is removed. After surgery, the results of UBM and Pentacam
examinations showed that the central anterior chambers of
patients in Group B are truly deeper than those in Group A,
but the opening degree of the chamber angle (Figure 9) is
poorer than those in Group A (Figure 10). In Group B, the iris
roots  of  some  patients  are  not  sufficiently  separated.  The
reasons for this might be that when GSL is performed on
patients in Group B, the lens is not available, as the supporting
points and the motion space at the pupillary margin for the iris
is quite large. When a certain amount of viscoelastic material
was filled in, the iris went down and the force acted on the
chamber angle is reduced. Some researchers [4] reported that
when  GSL  was  performed  after  the  crystalline  lens  was
removed,  synechia  was  appreciably  smaller  than  before
surgery  according  to  gonioscope  examinations  during
surgery. Mechanically pressing at the top of the iris root to
separate PAS, synechiae at the root of the iris was found
through an examination with a gonioscope, which may impair
the root of the chamber angle or the iris root and cause certain
impairment to the trabecular meshwork. According to the
report, the ratio of bleeding in angle separation, caused by
pressing the iris root with a blunt instrument, is about 11%
[12]. We find that the opening degree of a chamber angle was
preferable when the iris root was pressed with instruments in
Group B. Additionally, when the complications mentioned
above  occurred  easily,  the  surgical  operation  was  more
difficult to perform. The opening degree of the chamber angle
gradually decreased with time in group B. At 12 months after
the surgery, the examinations of 4 eyes in 3 patients showed
that the opening degrees were significantly smaller than those
at 1 month after surgery. The IOP of 2 eyes increased to
20 mmHg. The results of UBM and Pentacam examinations
showed that that opening degree of the anterior chamber angle
at 12 months after surgery was significantly smaller than at
one month post-surgery. As the patients did not return for
regular visit, as required, we were not sure whether the close-
up of the chamber angle was caused by the anterior chamber's
inflammation, the chamber’s bleeding after the surgery, or by
the surgery itself [15].
No one has reported the operation method of Group A
until now. We guess that the capacity of the anterior chamber
is  small  due  to  the  unremoved  expanded  crystalline  lens,
Figure 9. The group B show the chamber
angle  are  opening  at  12  month  after
operation (in terms of UBM).
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1080which may result in the limited opening degree of the chamber
angle. Moreover, the equal amount of viscoelastic material
filling the anterior chamber before the lens was removed may
easily increase the load of the lens’s suspensory ligament,
resulting in a tear. However, because of the limited downward
scope of the peripheral iris as the lens was not removed, the
dosage of viscoelastic material placed at the root of chamber
angle is more sufficient under the effect of equal dosage of
viscoelastic material. When viscoelastic material is filled, it
will press both the iris root and the center down, so that the
angle can be more sufficiently separated. Meanwhile, tears,
bleeding at the iris root, damage to trabecular meshwork and
other complications [12] can be reduced.
Others  have  reported  that  the  effect  of  GSL  was
negative .The reasons for the negative effect may be that the
separation was not abundant, and the synechia was still existed
after surgery. Through our observations, the opening degree
of the chamber angle was better in Group A than in Group B.
Therefore, we infer that GSL performed before the lens was
removed maybe the optional choice for patients of PACG
complicated with cataract.
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